Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: Ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam-Reference-Cited by-同舟云学术

Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: Ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam

Published:1996-03 Issue:3 Volume:7 Page:277-282
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Cunningham D.,Dicato M.,Verweij J.,Crombez R.,de Mulder P.,du Bois A.,Stewart A.,Smyth J.,Selby P.,van Straelen D.,Parideans R.,McQuade B.,McRae J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/7/3/277/663068/7-3-277.pdf

Reference15 articles.

1. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin;Kris;J Clin Oncol,1985

2. Incidence and duration of chemotherapy induced nausea and vomiting in the outpatient oncology population;Lindley;J Clin Oncol,1989

3. Ondansetron compared with high-dose metoclopramide in the prophylaxis of acute and delayed cisplatin induced nausea and vomiting;De Mulder;Ann Intern Med,1990

4. On the receiving end - patient perception of the side effects of cancer chemotherapy;Coates;Eur J Cancer Clin Oncol,1983

5. Comparison of the 5-hydroxytriptamine3, (serotonin) antagonist ondansetron (GR38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis;Marty;New Engl J Med,1990

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FAS and FASL variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients;Tumor Biology;2020-07

2. Morphology, Volume, and Density Characteristics of the Parotid Glands before and after Chemoradiation Therapy in Patients with Head and Neck Tumors;International Journal of Dentistry;2020-03-26

3. Daily challenges in oncology practice. What do we need to know about antiemetics?;Annals of Oncology;2006-09

4. Tolerability of the Compound ABHR in Hospice Patients;Journal of Palliative Medicine;2005-12

5. Pharmacoeconomic considerations of tropisetron for prophylaxis and treatment of CINV and PONV;Expert Review of Pharmacoeconomics & Outcomes Research;2003-10